CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 130 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,240,349 | +47.1% | 83,189 | +8.1% | 0.00% | – |
| Q2 2023 | $843,244 | +164.3% | 76,957 | +110.4% | 0.00% | – |
| Q1 2023 | $319,022 | +1287.1% | 36,585 | +401.0% | 0.00% | – |
| Q1 2022 | $23,000 | +21.1% | 7,302 | +31.4% | 0.00% | – |
| Q4 2021 | $19,000 | -5.0% | 5,558 | 0.0% | 0.00% | – |
| Q3 2021 | $20,000 | -16.7% | 5,558 | 0.0% | 0.00% | – |
| Q2 2021 | $24,000 | -44.2% | 5,558 | -41.2% | 0.00% | – |
| Q1 2021 | $43,000 | -20.4% | 9,457 | 0.0% | 0.00% | – |
| Q4 2020 | $54,000 | +22.7% | 9,457 | +54.9% | 0.00% | – |
| Q3 2020 | $44,000 | +46.7% | 6,106 | -28.2% | 0.00% | – |
| Q2 2020 | $30,000 | +50.0% | 8,503 | -36.7% | 0.00% | – |
| Q1 2020 | $20,000 | -37.5% | 13,434 | -18.1% | 0.00% | – |
| Q4 2019 | $32,000 | -54.9% | 16,404 | +19.3% | 0.00% | – |
| Q3 2019 | $71,000 | -27.6% | 13,746 | 0.0% | 0.00% | – |
| Q2 2019 | $98,000 | -30.0% | 13,746 | +29.7% | 0.00% | – |
| Q1 2019 | $140,000 | +79.5% | 10,595 | +6.6% | 0.00% | – |
| Q4 2018 | $78,000 | -29.1% | 9,941 | 0.0% | 0.00% | – |
| Q3 2018 | $110,000 | -17.9% | 9,941 | 0.0% | 0.00% | – |
| Q2 2018 | $134,000 | – | 9,941 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,254,502 | $20,741,000 | 14.54% |
| Versant Venture Management, LLC | 1,048,601 | $9,647,127,000 | 10.15% |
| Abingworth LLP | 1,147,077 | $10,553,000 | 7.65% |
| Omega Fund Management, LLC | 551,477 | $5,074,000 | 3.67% |
| Opaleye Management Inc. | 665,000 | $6,118,000 | 1.96% |
| DAFNA Capital Management LLC | 361,164 | $3,323,000 | 1.79% |
| Boxer Capital, LLC | 1,012,986 | $9,319,000 | 1.70% |
| Foresite Capital Management III, LLC | 600,000 | $5,520,000 | 1.55% |
| NEXTHERA CAPITAL LP | 536,568 | $4,936,000 | 0.91% |
| Perceptive Advisors | 2,685,882 | $24,710,000 | 0.82% |